Literature DB >> 2503470

High risk of mother-to-child transmission of HTLV-I in p40tax antibody-positive mothers.

T Sawada1, J Tohmatsu, T Obara, A Koide, S Kamihira, M Ichimaru, S Kashiwagi, W Kajiyama, N Matsumura, K Kinoshita.   

Abstract

A new enzyme-linked immunosorbent assay (ELISA) for detecting the antibody to a human T-lymphotropic virus type I (HTLV-I) tax gene product, p40tax, has been developed. By this ELISA method, we have investigated the relationship between the presence of p40tax antibody in HTLV-I-infected mothers and the virus transmission rate from mothers to their children. The rate of mother-to-child transmission of HTLV-I was higher in p40tax antibody-positive mothers than in antibody-negative ones. Thus, the presence of p40tax antibody may indicate an increased risk of vertical transmission of HTLV-I.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2503470      PMCID： PMC5917792          DOI： 10.1111/j.1349-7006.1989.tb01667.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN： 0910-5050


  20 in total

1.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Authors:  B K Felber; H Paskalis; C Kleinman-Ewing; F Wong-Staal; G N Pavlakis
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

2.  Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I.

Authors:  S L Cross; M B Feinberg; J B Wolf; N J Holbrook; F Wong-Staal; W J Leonard
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

3.  Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering.

Authors:  M Maruyama; H Shibuya; H Harada; M Hatakeyama; M Seiki; T Fujita; J Inoue; M Yoshida; T Taniguchi
Journal:  Cell       Date:  1987-01-30       Impact factor: 41.582

4.  Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor.

Authors:  J Fujisawa; M Seiki; T Kiyokawa; M Yoshida
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.

Authors:  K Kinoshita; K Yamanouchi; S Ikeda; S Momita; T Amagasaki; H Soda; M Ichimaru; R Moriuchi; S Katamine; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-12

6.  HTLV-I tax induces cellular proteins that activate the kappa B element in the IL-2 receptor alpha gene.

Authors:  D W Ballard; E Böhnlein; J W Lowenthal; Y Wano; B R Franza; W C Greene
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

7.  Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

Authors:  J G Sodroski; C A Rosen; W A Haseltine
Journal:  Science       Date:  1984-07-27       Impact factor: 47.728

8.  Characterization of a novel HTLV-infected cell line.

Authors:  H P Koeffler; I S Chen; D W Golde
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

9.  Oral transmission of human T-cell leukemia virus type-I into a common marmoset (Callithrix jacchus) as an experimental model for milk-borne transmission.

Authors:  K Yamanouchi; K Kinoshita; R Moriuchi; S Katamine; T Amagasaki; S Ikeda; M Ichimaru; T Miyamoto; S Hino
Journal:  Jpn J Cancer Res       Date:  1985-06

10.  A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus.

Authors:  J Sodroski; C Rosen; W C Goh; W Haseltine
Journal:  Science       Date:  1985-06-21       Impact factor: 47.728
View more
  7 in total

Review 1.  The epidemiology of HTLV-I infection.

Authors:  N Mueller
Journal:  Cancer Causes Control       Date:  1991-01       Impact factor: 2.506

2.  Serological evaluation of Escherichia coli-expressed human T-cell leukemia virus type I env, gag p24, and tax proteins.

Authors:  S R Coates; A J Harris; D L Parkes; C M Smith; H L Liu; R W Akita; M M Ferrer; E K Sampson; J W Brandis; M X Sliwkowski
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Population differences in immune marker profiles associated with human T-lymphotropic virus type I infection in Japan and Jamaica.

Authors:  Brenda M Birmann; Elizabeth C Breen; Sherri Stuver; Beverly Cranston; Otoniel Martínez-Maza; Kerstin I Falk; Akihiko Okayama; Barrie Hanchard; Nancy Mueller; Michie Hisada
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

4.  Human T-cell lymphotropic virus type 1 tax among American blood donors.

Authors:  D Zucker-Franklin; B A Pancake
Journal:  Clin Diagn Lab Immunol       Date:  1998-11

5.  Association between maternal antibodies to the external envelope glycoprotein and vertical transmission of human T-lymphotropic virus type I. Maternal anti-env antibodies correlate with protection in non-breast-fed children.

Authors:  S Hino; S Katamine; T Miyamoto; H Doi; Y Tsuji; T Yamabe; J E Kaplan; D L Rudolph; R B Lal
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

6.  Detection of antibodies to trans-activator protein (p40taxI) of human T-cell lymphotropic virus type I by a synthetic peptide-based assay.

Authors:  D L Rudolph; J E Coligan; R B Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-03

Review 7.  Mother-to-Child Transmission of HTLV-1 Epidemiological Aspects, Mechanisms and Determinants of Mother-to-Child Transmission.

Authors:  Florent Percher; Patricia Jeannin; Sandra Martin-Latil; Antoine Gessain; Philippe V Afonso; Aurore Vidy-Roche; Pierre-Emmanuel Ceccaldi
Journal:  Viruses       Date:  2016-02-03       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.